Halozyme Therapeutics, Inc. (NASDAQ:HALO)

CAPS Rating: 2 out of 5

A biopharmaceutical company dedicated to the development and commercialization of recombinant human enzymes for the drug delivery, palliative care, oncology and infertility markets.

Recs

0
Player Avatar Joe1988 (78.25) Submitted: 6/4/2007 10:11:30 AM : Outperform Start Price: $2.82 HALO Score: +194.34

This is an Awesome stock that just keeps increasing! What else can I say?!

Report this Post 1 Comment
Member Avatar Somnambulo (96.41) Submitted: 6/10/2007 10:03:19 PM
Recs: 0

What else can you say? How about when you think they will become profitable.

Featured Broker Partners


Advertisement